
SweetBio, Inc. is a Memphis-based medical device company that bioengineers manuka honey into solid, easy-to-apply wound dressings. Its flagship product, APIS, combines a collagen derivative, UMF-certified manuka honey, and hydroxyapatite into a trimmable sheet that is FDA-cleared and Medicare-covered for managing chronic and acute wounds, including diabetic foot ulcers. Founded in 2015 by sibling co-founders Kayla Rodriguez Graff and Dr. Isaac Rodriguez, the woman-led, Latinx-founded company aims to make advanced wound care accessible and affordable - taking a remedy as old as the ancient Egyptians and delivering it in a modern, standardized form.
Kayla Rodriguez Graff is the co-founder and CEO of SweetBio, a Memphis-based medical device company bioengineering Manuka honey, collagen, and hydroxyapatite into FDA-cleared, Medicare-covered wound care products (APIS and VERIS). She runs the company with her brother, scientist Dr. Isaac Rodriguez, and has raised more than $10M to expand access to affordable wound care, especially in communities hit hardest by diabetes.
Agora is a real-time engagement platform that gives developers simple APIs and SDKs to embed live voice, video, interactive streaming, chat, and conversational AI into apps and devices. Trusted by more than 1,700 organizations across social, live shopping, education, telehealth, and gaming, Agora's network reaches devices worldwide with sub-second latency. The company trades on Nasdaq under the ticker API.

Tiffany Luck is a Partner at NEA (New Enterprise Associates), one of the world's largest and oldest venture capital firms, where she focuses on early-stage investments in AI, APIs, and B2B SaaS. Previously a Partner at GGV Capital (now Notable Capital), she brings deep experience across enterprise software, fintech, and the AI application layer. Tiffany has a rare blend of operating, banking, and investing experience - having worked at Forbes, Amazon, and Morgan Stanley before entering venture. She is known for backing founders obsessed with their problems and for her thesis around vertical AI closing the 'last mile' gap that horizontal LLMs leave wide open.